Luis Fernando Fernández-Fuertes
Luis Fernando Fernández-Fuertes has a total of 45 co-authors. Here are the top co-authors by number of shared publications:
- Abelardo Bárez
Hematology Department, Nuestra Señora de Sonsoles, Ávila, Spain
2 shared publications - Carlos Grande-García
Hematology Department, Clínica Universidad de Navarra, 28022 Madrid, Spain
2 shared publications - Cristina Pascual-Izquierdo
Hospital General Universitario Gregorio Marañón Madrid Spain
2 shared publications - Daniel Martínez-Carballeira
Department of Hematology, Hospital Universitario Central de Asturias (HUCA), 33011 Oviedo, Spain
2 shared publications - David Valcárcel
Myeloid Malignancies Research Group, Vall d’hebron Institute of oncology (VHIO), Hospital Vall d’hebron, Universitat Aùtonoma de Barcelona, Barcelona, Spain
2 shared publications - Elsa López-Ansoar
Hematology Department, Complejo Hospitalario Universitario de Vigo, 36312 Vigo, Spain
2 shared publications
Latest Publications
- Open Access
- 10 October 2023
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 12 (20) , 6422
Recommendations for the Clinical Approach to Immune Thrombocytopenia: Spanish ITP Working Group (GEPTI)
Primary immune thrombocytopenia (ITP) is a complex autoimmune disease whose hallmark is a deregulation of cellular and humoral immunity leading to increased destruction and reduced production of platelets. The heterogeneity of presentation and clinical course hampers personalized approaches for diagnosis and management. In 2021, the Spanish ITP Group (GEPTI) of the Spanish Society of Hematology and Hemotherapy (SEHH) updated a consensus document that had been launched in 2011. The updated guidelines have been the reference for the diagnosis and management of primary ITP in Spain ever since. Nevertheless, the emergence of new tools and strategies makes it advisable to review them again. For this reason, we have updated the main recommendations appropriately. Our aim is to provide a practical tool to facilitate the integral management of all aspects of primary ITP management.
- 10 October 2023
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 12 (20) , 6422
Open AccessRecommendations for the Clinical Approach to Immune Thrombocytopenia: Spanish ITP Working Group (GEPTI)
Primary immune thrombocytopenia (ITP) is a complex autoimmune disease whose hallmark is a deregulation of cellular and humoral immunity leading to increased destruction and reduced production of platelets. The heterogeneity of presentation and clinical course hampers personalized approaches for diagnosis and management. In 2021, the Spanish ITP Group (GEPTI) of the Spanish Society of Hematology and Hemotherapy (SEHH) updated a consensus document that had been launched in 2011. The updated guidelines have been the reference for the diagnosis and management of primary ITP in Spain ever since. Nevertheless, the emergence of new tools and strategies makes it advisable to review them again. For this reason, we have updated the main recommendations appropriately. Our aim is to provide a practical tool to facilitate the integral management of all aspects of primary ITP management.
- Open Access
- 6 September 2023
- Published by MDPI AG in Preprints.org
Recommendations for the Clinical Approach to Primary Immune Thrombocytopenia
Primary immune thrombocytopenia (ITP) is a complex autoimmune disease whose hallmark is a deregulation of cellular and humoral immunity leading to an increased destruction and a reduced production of platelets. The heterogeneity of presentation and clinical course hampers personalized approaches for diagnosis and management. In 2021, the Spanish ITP Group (GEPTI) of the Spanish Society of Hematology and Hemotherapy (SEHH) updated a consensus document which had been launched in 2011. The updated guidelines have been the reference for diagnosis and management of primary ITP in Spain ever since. Nevertheless, the emergence of new tools and strategies makes it advisable to review them again. For this reason, we have properly updated the main recommendations. Our aim is to provide a practical tool to enable the integral management of all the aspects concerning primary ITP management.
- 6 September 2023
- Published by MDPI AG in Preprints.org
Open AccessRecommendations for the Clinical Approach to Primary Immune Thrombocytopenia
Primary immune thrombocytopenia (ITP) is a complex autoimmune disease whose hallmark is a deregulation of cellular and humoral immunity leading to an increased destruction and a reduced production of platelets. The heterogeneity of presentation and clinical course hampers personalized approaches for diagnosis and management. In 2021, the Spanish ITP Group (GEPTI) of the Spanish Society of Hematology and Hemotherapy (SEHH) updated a consensus document which had been launched in 2011. The updated guidelines have been the reference for diagnosis and management of primary ITP in Spain ever since. Nevertheless, the emergence of new tools and strategies makes it advisable to review them again. For this reason, we have properly updated the main recommendations. Our aim is to provide a practical tool to enable the integral management of all the aspects concerning primary ITP management.
- Open Access
Association between Heavy Metals and Rare Earth Elements with Acute Ischemic Stroke: A Case-Control Study Conducted in the Canary Islands (Spain)
The role of inorganic elements as risk factors for stroke has been suggested. We designed a case-control study to explore the role of 45 inorganic elements as factors associated with stroke in 92 patients and 83 controls. Nineteen elements were detected in >80% of patients and 21 were detected in >80% of controls. Blood level of lead was significantly higher among patients (11.2 vs. 9.03 ng/mL) while gold and cerium were significantly higher among controls (0.013 vs. 0.007 ng/mL; and 18.0 vs. 15.0 ng/mL). Lead was associated with stroke in univariate and multivariate analysis (OR = 1.65 (95% CI, 1.09–2.50) and OR = 1.91 (95% CI, 1.20–3.04), respectively). Gold and cerium showed an inverse association with stroke in multivariate analysis (OR = 0.81 (95% CI, 0.69–0.95) and OR = 0.50 (95% CI, 0.31–0.78)). Future studies are needed to elucidate the potential sources of exposure and disclose the mechanisms of action.
Open AccessAssociation between Heavy Metals and Rare Earth Elements with Acute Ischemic Stroke: A Case-Control Study Conducted in the Canary Islands (Spain)
The role of inorganic elements as risk factors for stroke has been suggested. We designed a case-control study to explore the role of 45 inorganic elements as factors associated with stroke in 92 patients and 83 controls. Nineteen elements were detected in >80% of patients and 21 were detected in >80% of controls. Blood level of lead was significantly higher among patients (11.2 vs. 9.03 ng/mL) while gold and cerium were significantly higher among controls (0.013 vs. 0.007 ng/mL; and 18.0 vs. 15.0 ng/mL). Lead was associated with stroke in univariate and multivariate analysis (OR = 1.65 (95% CI, 1.09–2.50) and OR = 1.91 (95% CI, 1.20–3.04), respectively). Gold and cerium showed an inverse association with stroke in multivariate analysis (OR = 0.81 (95% CI, 0.69–0.95) and OR = 0.50 (95% CI, 0.31–0.78)). Future studies are needed to elucidate the potential sources of exposure and disclose the mechanisms of action.
- 6 July 2010
- Published by Wiley in Therapeutic Apheresis and Dialysis
- Vol. 14 (5) , 484-485
Low‐Density Lipoprotein Apheresis Using Double Filtration Plasmapheresis: 27‐Month Use in a Child With Homozygous Familial Hypercholesterolemia
- 6 July 2010
- Published by Wiley in Therapeutic Apheresis and Dialysis
- Vol. 14 (5) , 484-485
Low‐Density Lipoprotein Apheresis Using Double Filtration Plasmapheresis: 27‐Month Use in a Child With Homozygous Familial Hypercholesterolemia